title: [Characteristic and clinicopathologic significance of lymphangiogenesis in colorectal cancer].
abstract: OBJECTIVE
  To investigate the distribution patterns and proliferative activity of lymphatic vessels in colorectal carcinomas (CRC) and their relationship with tumor metastasis and disease prognosis.
  
  
  METHODS
  The microlymphatic density (MLD) and microvascular density in tumoral and non-tumoral areas of 96 cases of CRC were evaluated by immunohistochemistry, using monoclonal antibodies for podoplanin and CD34 respectively. The Ki-67 expression of the lymphatic and blood vessels was detected by double-labeling immunohistochemistry. The relationship between MLD and clinicopathologic features and prognosis was analyzed.
  
  
  RESULTS
  The lymph vessels at central and superficia1 portions of CRC often had a reticular architecture with numerous tiny and ill-defined lumina, while those at the tumor borders had large and open lumina. The MLD at tumor borders (51.2 +/- 25.5) was significantly higher than that in normal colorectal mucosa (29.4 +/- 9.0) and other portions of CRC (P < 0.01). The Ki-67 labeling index of the lymphatic lining cells at tumor borders (0.23 +/- 0.17) was significantly higher than that in other portions of CRC (P < 0.05). The MLD significantly correlated with lymphatic involvement by tumor cells, regional lymph node metastasis and distant metastasis (P < 0.01). The 5-year survival rate was also significantly lower in patients with high MLD (P < 0.05).
  
  
  CONCLUSIONS
  Neolymphatic vessels are commonly seen in CRC, especially at tumor borders. High MLD at tumor borders is associated with metastasis. The detection of MLD at tumor borders may thus be useful in predicting lymph node metastasis and prognosis in patients with CPC.
authors.affiliation: Institute of Pathology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
authors.forename: Jiang-hong
authors.initials: JH
authors.lastname: Mou
authors.forename: Xiao-chu
authors.initials: XC
authors.lastname: Yan
authors.forename: Zeng-peng
authors.initials: ZP
authors.lastname: Li
authors.forename: Dong
authors.initials: D
authors.lastname: Wang
authors.forename: Guang-jie
authors.initials: GJ
authors.lastname: Duan
authors.forename: De-bing
authors.initials: DB
authors.lastname: Xiang
authors.forename: Hua-liang
authors.initials: HL
authors.lastname: Xiao
authors.forename: Qin-hong
authors.initials: QH
authors.lastname: Zhang
mesh_terms: D000230:Adenocarcinoma / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015179:Colorectal Neoplasms / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000276:immunology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019394:Ki-67 Antigen / Q000378:metabolism; D042583:Lymphangiogenesis; D008207:Lymphatic Metastasis; D042601:Lymphatic Vessels / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D015996:Survival Rate
chemical_list: D019394:Ki-67 Antigen